United States · FDA National Drug Code directory
TAZVERIK
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72607-100_c4bd8d8a-22c1-4911-a9b4-7368582d8e5d
- Product NDC
- 72607-100
- Form
- TABLET, FILM COATED
- Composition / generic term
- tazemetostat
- Labeler
- Epizyme, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20200123 / 20290430
Source-listed ingredients
- TAZEMETOSTAT HYDROBROMIDE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 240 TABLET, FILM COATED in 1 BOTTLE (72607-100-00) · 72607-100-00
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →